Menu

Search

Nial Wheate

Nial Wheate

Senior Lecturer in Pharmaceutics, University of Sydney

Dr Wheate completed a Bachelor of Science degree with 1st class honours from the University of New South Wales whilst at the Australian Defence Force Academy. He then completed a PhD in medicinal chemistry under Professor J. Grant Collins. Since then he has worked in the School of Biomedical and Health Sciences at the University of Western Sydney (Australia) and the Strathclyde Institute of Pharmacy and Biomedical Science (Scotland) before taking up a position in the Faculty of Pharmacy at the University of Sydney (Australia) in 2012.

Dr Wheate's research interests lie in whole-of-pipeline discovery and development of platinum-based anticancer drugs including: design and synthesis, in vitro and in vivo screening, drug-DNA binding, nanoparticle based delivery, solid state chemistry and co-crystals, toxicology and pharmacokinetics, and dosage formulation. Additionally, his research also examines the drug delivery application of macrocycles (including cyclodextrins, cucurbiturils and pillararenes) and their host-guest complexes.

Dr Wheate was previously the Head of Cancer Research in the Faculty of Pharmacy.

Weekly Dose: methylprednisolone, a drug for treating inflammation but not rare kidney disease

Aug 03, 2017 16:37 pm UTC| Health

Methylprednisolone is a prescription drug used to treat conditions involving inflammation, like asthma, arthritis, gout, tendinitis, transplant rejection, allergic reactions, and the skin conditions eczema and...

Explainer: what is chemotherapy and how does it work?

Jun 01, 2017 14:12 pm UTC| Health

Chemotherapy is the use of drugs to treat cancer in humans and animals. It is rarely used in isolation and is often paired with surgery, radiotherapy and immunotherapy, or a combination of these. Chemotherapy works by...

New drugs on the PBS: what they do and why we need them

May 05, 2017 02:05 am UTC| Insights & Views Health

This week, the government announced the latest additions, amendments, and deletions from the Pharmaceutical Benefits Scheme (PBS): the program through which essential medicines are subsidised for Australian patients. The...

Fentanyl, the anaesthetic that may have been used as a chemical weapon on Chechen rebels

Jul 27, 2016 07:35 am UTC| Health

Fentanyl is a synthetic analgesic (pain relieving) drug in the same class as morphine. It is used to treat acute or chronic pain, including for epidurals given to women during childbirth. It is thought that in 2002...

1 

Economy

Viksit Bharat 2026: Fiscal Muscle, Factory Revival, and the War on Speculation

Finance Minister Nirmala Sitharamans Union Budget 202627 pursues the Viksit Bharat vision vigorously by combining severe fiscal discipline with a huge growth push. Driven by a 7% GDP growth objective and a lowered fiscal...

EU Recovery Fund Faces Bottlenecks Despite Driving Digital and Green Projects

Across Spains olive groves and vineyards, sensors and drones funded by the European Unions massive post-pandemic recovery plan are collecting soil data to power AI-driven farming. These projects reflect the core ambition...

Asian Markets Slide as Silver Volatility, Earnings Season, and Central Bank Meetings Rattle Investors

Asian share markets opened the week on a cautious note, largely tracking weaker Wall Street futures, as extreme volatility in silver prices and a packed global economic calendar unsettled investors. The sharp moves in...

India Budget 2025 Highlights Manufacturing Push but Falls Short of Market Expectations

Indias latest Union Budget placed manufacturing firmly at the center of its economic strategy, prioritizing key sectors such as semiconductors, biopharma, electronics, renewables, and capital goods. While the government...

Starmer’s China Visit Highlights Western Balancing Act Amid U.S.-China Rivalry

British Prime Minister Keir Starmers recent visit to China underscores the complex balancing act Western middle powers are attempting as rivalry between Beijing and Washington intensifies. While the trip allowed China to...

Politics

Medvedev Warns World Is Growing More Dangerous but Says Russia Seeks to Avoid Global Conflict

Dmitry Medvedev, Russias deputy chairman of the Security Council and a senior Kremlin security official, has warned that the global situation is becoming increasingly dangerous, while stressing that Russia does not want a...

Laura Fernandez Set to Become Costa Rica’s Next President, Promising Sweeping Political Change

Laura Fernandez is poised to become Costa Ricas next president, marking a significant political shift as she pledges to continue and deepen the populist agenda of outgoing President Rodrigo Chaves. Her victory signals a...

Peter Mandelson Resigns from Labour Party Amid Renewed Jeffrey Epstein Links

Former British government minister Peter Mandelson has resigned from Prime Minister Keir Starmers Labour Party following renewed media scrutiny over his past connections to disgraced U.S. financier Jeffrey Epstein. The...

Japan Election Poll Signals Landslide Win for Sanae Takaichi, Raising Fiscal Policy Concerns

Japans ruling Liberal Democratic Party (LDP), led by Prime Minister Sanae Takaichi, is poised for a decisive victory in the upcoming lower house election, according to a new opinion poll released by the Asahi newspaper....

U.S. Accuses Cuba of Harassing Top Diplomat Amid Rising Tensions

The United States has accused Cuba of interfering with the work of its senior diplomat in Havana after videos emerged showing small groups of Cubans verbally harassing him during visits outside the capital. The incident...

Science

NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern

NASA has confirmed that the agency, in coordination with SpaceX, is targeting no earlier than 5 p.m. Eastern Time (2200 GMT) on Wednesday, January 14, for the undocking of the SpaceX Crew-11 mission from the International...

Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026

Elon Musks brain-computer interface company Neuralink is preparing for a major expansion, announcing plans to begin high-volume production of its brain implant devices and transition to a fully automated surgical procedure...

Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency

The U.S. Senate has officially confirmed billionaire private astronaut Jared Isaacman as the new NASA administrator, making him the 15th leader in the agencys history. The confirmation, which took place on Wednesday, marks...

Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman

The U.S. Senate Commerce Committee announced it will vote on December 8 on President Donald Trumps renewed nomination of private astronaut and tech entrepreneur Jared Isaacman to lead NASA. Isaacman, known for his...

NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead

NASA has significantly scaled back Boeings Starliner program after years of technical issues and delays, announcing that the next Starliner mission to the International Space Station (ISS) will fly without astronauts. The...

Technology

Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure

Oracle has announced plans to raise between $45 billion and $50 billion in 2026 as it accelerates the expansion of its cloud infrastructure to meet surging demand from major technology and artificial intelligence clients....

SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers

Elon Musks SpaceX is seeking approval from the U.S. Federal Communications Commission (FCC) for an ambitious plan to launch up to 1 million satellites into Earths orbit, aiming to harness solar energy in space to power AI...

Nvidia Confirms Major OpenAI Investment Amid AI Funding Race

Nvidia CEO Jensen Huang has confirmed that the chipmaking giant plans to make a massive investment in OpenAI, calling it likely the largest investment Nvidia has ever made. Speaking to reporters in Taipei, Huang dismissed...

Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate

Speculation around a potential Musk Inc has resurfaced as Elon Musks companiesSpaceX, Tesla, and xAIexplore closer ties amid rapid advances in artificial intelligence and automation. With SpaceX expected to go public later...

SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz

SpaceX delivered a strong financial performance last year, generating an estimated $8 billion in profit on revenues between $15 billion and $16 billion, according to people familiar with the companys results. The figures,...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.